Pneumococcal vaccine in the elderly: the Norwegian experience.

Aaberge IS

首页> 外文期刊>Drugs and aging >Pneumococcal vaccine in the elderly: the Norwegian experience.

【24h】

Pneumococcal vaccine in the elderly: the Norwegian experience.

机译：老年人肺炎球菌疫苗：挪威的经验。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Pneumococcal infections have increased during the last 10 to 15 years in Norway. Their incidence is now about 20 per 100,000 population for all age groups, but is 2 to 3 times higher among the elderly. In 1996, the Advisory Board of Infectious Disease Control, National Institute of Public Health, Norway, recommended that pneumococcal polysaccharide vaccine should be administered to all individuals aged > or = 65 years. This recommendation has led to an increased use of pneumococcal vaccine, with a marked peak during the influenza vaccination season.

机译：在过去的10到15年中，挪威的肺炎球菌感染有所增加。现在，所有年龄段的人群的发病率约为每10万人中20例，但老年人群的发病率是2至3倍。 1996年，挪威国家公共卫生研究所传染病控制咨询委员会建议，应对所有年龄≥65岁的人接种肺炎球菌多糖疫苗。该建议导致增加了肺炎球菌疫苗的使用，在流感疫苗接种季节出现了明显的高峰。

著录项

来源
《Drugs and aging》 |1999年第1期|共5页
作者
Aaberge IS;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
Bacterial Vaccines; Cost-Benefit Analysis; Pneumococcal Infections; Polysaccharides; Bacterial; 细菌菌苗; 费用效益分析; 肺炎球菌感染;

机译：Bacterial Vaccines;Cost-Benefit Analysis;Pneumococcal Infections;Polysaccharides;Bacterial;细菌菌苗;费用效益分析;肺炎球菌感染;

相似文献

外文文献
中文文献
专利

1. Pneumococcal vaccine in the elderly: the Norwegian experience. [J] . Aaberge IS Drugs and aging . 1999,第Suppla1期

机译：老年人肺炎球菌疫苗：挪威的经验。
2. Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study [J] . Vaccine . 2019,第21期

机译：肺炎球菌疫苗疫苗对肺炎球菌共轭疫苗时代的老年人口侵袭性肺炎球菌疫苗和非杀菌性肺炎球菌肺炎的直接有效性：病例对照研究
3. Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly [J] . Seo Yu Bin, Choi Won Suk, Lee Jacob, Clinical and Experimental Vaccine Research . 2017,第1期

机译：老年人同时使用13价肺炎球菌结合疫苗或23价多糖肺炎球菌疫苗同时接种流感疫苗的免疫原性和安全性比较
4. Pneumococcal proteins that may constitute the next generation vaccine for pneumococcal disease [C] . David E. Briles, Susan K. Hollingshead, Marilyn J. Crain, International Symposium on Tonsils and Mucosal Barriers of Upper Airways . 2003

机译：肺炎球菌蛋白，可构成肺炎球菌病的下一代疫苗
5. Impact of Pneumococcal Conjugate Vaccine Thirteen Valent on the Reduction of Invasive Pneumococcal Disease. [D] . Coulibaly, Aissata. 2016

机译：肺炎球菌结合疫苗十三价对减少侵袭性肺炎球菌疾病的影响。
6. Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly [O] . Yu Bin Seo, Won Suk Choi, Jacob Lee, 2017

机译：老年人同时使用13价肺炎球菌结合疫苗或23价多糖肺炎球菌疫苗同时接种流感疫苗的免疫原性和安全性比较
7. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience. [O] . Vincenzo Baldo, Silvia Cocchio, Tolinda Gallo, 2016

机译：肺炎球菌共轭疫苗降低了老年人社区获得性肺炎的高死亡率：意大利的区域经验。

Pneumococcal vaccine in the elderly: the Norwegian experience.

摘要

著录项

相似文献

相关主题

期刊订阅